Anaphylactic shock depends on endothelial Gq/G11

Journal of Experimental Medicine

Volumn 206, Issue 2, 2009, Pages 411-420

  Korhonen, Hanna ^a   Fisslthaler, Beate ^b   Moers, Alexandra ^a   Wirth, Angela ^a   Habermehl, Daniel ^c   Wieland, Thomas ^a   Schütz, Günther ^c   Wettschureck, Nina ^a   Fleming, Ingrid ^b   Offermanns, Stefan ^a,d  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Institute for Cardiovascular Physiology   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CRE RECOMBINASE; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HISTAMINE; NITRIC OXIDE; THROMBOCYTE ACTIVATING FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANAPHYLACTIC SHOCK; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; LOXP SITE; MEDIATOR; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANAPHYLAXIS; ANIMAL; BLOOD PRESSURE; BODY TEMPERATURE; COMPARATIVE STUDY; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; TELEMETRY;

ANAPHYLAXIS; ANIMALS; BLOOD PRESSURE; BODY TEMPERATURE; ENDOTHELIAL CELLS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; MICE; NITRIC OXIDE; PHOSPHORYLATION; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; TELEMETRY;

EID: 63049113496     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20082150     Document Type: Article

References (60)

1. Clark, S., and C.A. Camargo Jr. 2007. Epidemiology of anaphylaxis. Immunol. Allergy Clin. North Am. 27:145-163.
2. Kemp, S.F., and R.F. Lockey. 2002. Anaphylaxis: a review of causes and mechanisms. J. Allergy Clin. Immunol. 110:341-348.
3. Neugut, A.I., A.T. Ghatak, and R.L. Miller. 2001. Anaphylaxis in the United States: an investigation into its epidemiology. Arch. Intern. Med. 161:15-21.
4. Sampson, H.A., A. Munoz-Furlong, R.L. Campbell, N.F. Adkinson Jr., S.A. Bock, A. Branum, S.G. Brown, C.A. Camargo Jr., R. Cydulka, S.J. Galli, et al. 2006. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J. Allergy Clin. Immunol. 117:391-397.
5. Finkelman, F.D., and D. Vercelli. 2007. Anaphylaxis: lessons from mouse models. J. Allergy Clin. Immunol. 120:506-515.
6. Schwartz, L.B. 2002. Mast cells and basophils. Clin. Allergy Immunol. 16:3-42.
7. Ogawa, Y., and J.A. Grant. 2007. Mediators of anaphylaxis. Immunol. Allergy Clin. North Am. 27:249-260.
8. Compton, S.J., J.J. McGuire, M. Saifeddine, and M.D. Hollenberg. 2002. Restricted ability of human mast cell tryptase to activate proteinase- activated receptor-2 in rat aorta. Can. J. Physiol. Pharmacol. 80:987-992.
9. Hill, S.J., C.R. Ganellin, H. Timmerman, J.C. Schwartz, N.P. Shankley, J.M. Young, W. Schunack, R. Levi, and H.L. Haas. 1997. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol. Rev. 49:253-278.
10. Montrucchio, G., G. Alloatti, and G. Camussi. 2000. Role of platelet-activating factor in cardiovascular pathophysiology. Physiol. Rev. 80:1669-1699.
11. Ramachandran, R., and M.D. Hollenberg. 2008. Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more. Br. J. Pharmacol. 153:S263-S282.
12. Sendo, T., T. Sumimura, Y. Itoh, T. Goromaru, K. Aki, T. Yano, M. Oike, Y. Ito, S. Mori, M. Nishibori, and R. Oishi. 2003. Involvement of proteinase-activated receptor-2 in mast cell tryptase- induced barrier dysfunction in bovine aortic endothelial cells. Cell. Signal. 15:773-781.
13. Haribabu, B., M.W. Verghese, D.A. Steeber, D.D. Sellars, C.B. Bock, and R. Snyderman. 2000. Targeted disruption of the leukotriene B4 receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis. J. Exp. Med. 192:433-438.
14. Prescott, S.M., G.A. Zimmerman, D.M. Stafforini, and T.M. McIntyre. 2000. Platelet-activating factor and related lipid mediators. Annu. Rev. Biochem. 69:419-445.
15. Austen, K.F. 2005. The mast cell and the cysteinyl leukotrienes. Novartis Found. Symp. 271:166-175.
16. Brink, C., S.E. Dahlen, J. Drazen, J.F. Evans, D.W. Hay, S. Nicosia, C.N. Serhan, T. Shimizu, and T. Yokomizo. 2003. International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors. Pharmacol. Rev. 55:195-227.
17. Marone, G., M. Bova, A. Detoraki, A.M. Onorati, F.W. Rossi, and G. Spadaro. 2004. The human heart as a shock organ in anaphylaxis. Novartis Found. Symp. 257:133-149.
18. Bellizzi, M.J., S.M. Lu, E. Masliah, and H.A. Gelbard. 2005. Synaptic activity becomes excitotoxic in neurons exposed to elevated levels of platelet-activating factor. J. Clin. Invest. 115:3185-3192.
19. Kasperska-Zajac, A., and B. Rogala. 2006. Platelet function in anaphy- laxis. J. Investig. Allergol. Clin. Immunol. 16:1-4.
20. Brown, S.L., V.R. Jala, S.K. Raghuwanshi, M.W. Nasser, B. Haribabu, and R.M. Richardson. 2006. Activation and regulation of platelet-activating factor receptor: role of G(i) and G(q) in receptor-mediated chemotactic, cytotoxic, and cross-regulatory signals. J. Immunol. 177:3242-3249.
21. Honda, Z., S. I shii, and T. Shimizu. 2002. Platelet-activating factor receptor. J. Biochem. 131:773-779.
22. Kato, M., H. Kimura, Y. Motegi, A. Tachibana, H. Minakami, A. Morikawa, and H. Kita. 2002. Platelet-activating factor activates two distinct effector pathways in human eosinophils. J. Immunol. 169:5252-5259.
23. Nielsen, C.K., R. Massoumi, M. Sonnerlind, and A. Sjolander. 2005. Leukotriene D4 activates distinct G-proteins in intestinal epithelial cells to regulate stress fibre formation and to generate intracellular Ca2+ mobilisation and ERK1/2 activation. Exp. Cell Res. 302:31-39.
24. Seifert, R., L. Grunbaum, and G. Schultz. 1994. Histamine H1-re- ceptors in HL-60 monocytes are coupled to Gi-proteins and pertussis toxin-insensitive G-proteins and mediate activation of Ca2+ influx without concomitant Ca2+ mobilization from intracellular stores. Naunyn Schmiedebergs Arch. Pharmacol. 349:355-361.
25. Birnbaumer, L. 2007. Expansion of signal transduction by G proteins. The second 15 years or so: from 3 to 16 alpha subunits plus betagamma dimers. Biochim. Biophys. Acta. 1768:772-793.
26. Milligan, G., and E. Kostenis. 2006. Heterotrimeric G-proteins: a short history. Br. J. Pharmacol. 147:S46-S55.
27. Oldham, W.M., and H.E. Hamm. 2008. Heterotrimeric G protein activation by G-protein-coupled receptors. Nat. Rev. Mol. Cell Biol. 9:60-71.
28. Wettschureck, N., and S. Offermanns. 2005. Mammalian G proteins and their cell type specific functions. Physiol. Rev. 85:1159-1204.
29. Moers, A., B. Nieswandt, S. Massberg, N. Wettschureck, S. Gruner, I. Konrad, V. Schulte, B. Aktas, M.P. Gratacap, M.I. Simon, et al. 2003. G13 is an essential mediator of platelet activation in hemostasis and thrombosis. Nat. Med. 9:1418-1422.
30. Wettschureck, N., H. Rutten, A. Zywietz, D. Gehring, T.M. Wilkie, J. Chen, K.R. Chien, and S. Offermanns. 2001. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes. Nat. Med. 7:1236-1240.
31. Indra, A.K., X. Warot, J. Brocard, J.M. Bornert, J.H. Xiao, P. Chambon, and D. Metzger. 1999. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombi- nases. Nucleic Acids Res. 27:4324-4327.
32. Braquet, P., P. Guinot, and C. Touvay. 1987. The role of PAF-acether in anaphylaxis demonstrated with the use of the antagonist BN 52021. Agents Actions Suppl. 21:97-117.
33. Ishii, S., T. Kuwaki, T. Nagase, K. Maki, F. Tashiro, S. Sunaga, W.H. Cao, K. Kume, Y. Fukuchi, K. Ikuta, et al. 1998. Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet- activating factor receptor. J. Exp. Med. 187:1779-1788.
34. Vadas, P., M. Gold, B. Perelman, G.M. Liss, G. Lack, T. Blyth, F.E. Simons, K.J. Simons, D. Cass, and J. Yeung. 2008. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N. Engl. J. Med. 358:28-35.
35. Brown, S.G.A. 2007. The pathophysiology of shock in anaphylaxis. In Immunology and Allergy Clinics of North America: Anaphylaxis. P. Lieberman, and R. Alam, editors. Saunders, Philadelphia, London, Toronto. 165-175.
36. Schwartz, L.B. 2004. Effector cells of anaphylaxis: mast cells and basophils. In Anaphylaxis. G. Bock, and J. Goode, editors. John Wiley &Sons, Ltd., Chichester, U.K. 65-79.
37. Gu, J.L., S. Muller, V. Mancino, S. Offermanns, and M.I. Simon. 2002. Interaction of G alpha(12) with G alpha(13) and G alpha(q) signaling pathways. Proc. Natl. Acad. Sci. USA. 99:9352-9357.
38. Offermanns, S., V. Mancino, J.P. Revel, and M.I. Simon. 1997. Vascular system defects and impaired cell chemokinesis as a result of Galpha13 deficiency. Science. 275:533-536.
39. Offermanns, S., L.P. Zhao, A. Gohla, I. Sarosi, M.I. Simon, and T.M. Wilkie. 1998. Embryonic cardiomyocyte hypoplasia and craniofacial defects in G alpha q/G alpha 11-mutant mice. EMBO J. 17:4304-4312.
40. Ruppel, K.M., D. Willison, H. Kataoka, A. Wang, Y.W. Zheng, I. Cornelissen, L. Yin, S.M. Xu, and S.R. Coughlin. 2005. Essential role for Galpha13 in endothelial cells during embryonic development. Proc. Natl. Acad. Sci. USA. 102:8281-8286.
41. Garcia, J.G.N. 2007. Regulation of endothelial barrier responses and permeability. In Endothelial Biomedicine. W.C. Aird, editor. Cambridge United Press, Cambridge, MA. 1015-1029.
42. Mehta, D., and A.B. Malik. 2006. Signaling mechanisms regulating en- dothelial permeability. Physiol. Rev. 86:279-367.
43. Goeckeler, Z.M., and R.B. Wysolmerski. 1995. Myosin light chain kinase-regulated endothelial cell contraction: the relationship between isometric tension, actin polymerization, and myosin phosphorylation. J. Cell Biol. 130:613-627.
44. Minshall, R.D., and A.B. Malik. 2006. Transport across the endothe- lium: regulation of endothelial permeability. Handb. Exp. Pharmacol. 176:107-144.
45. Somlyo, A.P., and A.V. Somlyo. 2003. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol. Rev. 83:1325-1358.
46. Wirth, A., Z. Benyo, M. Lukasova, B. Leutgeb, N. Wettschureck, S. Gorbey, P. Orsy, B. Horvath, C. Maser-Gluth, E. Greiner, et al. 2008. G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nat. Med. 14:64-68.
47. Gohla, A., G. Schultz, and S. Offermanns. 2000. Role for G(12)/G(13) in agonist-induced vascular smooth muscle cell contraction. Circ. Res. 87:221-227.
48. Gavard, J., and J.S. Gutkind. 2008. Protein kinase C-related kinase and ROCK are required for thrombin-induced endothelial cell permeability downstream from Galpha 12/13 and Galpha 11/q. J. Biol. Chem. 283:29888-29896.
49. Amir, S., and A.M. English. 1991. An inhibitor of nitric oxide production, NG-nitro-L-arginine-methyl ester, improves survival in anaphy- lactic shock. Eur. J. Pharmacol. 203:125-127.
50. Mitsuhata, H., J. Saitoh, N. Hasome, H. Takeuchi, Y. Horiguchi, and R. Shimizu. 1995. Nitric oxide synthase inhibition is detrimental to cardiac function and promotes bronchospasm in anaphylaxis in rabbits. Shock. 4:143-148.
51. Cauwels, A., B. Janssen, E. Buys, P. Sips, and P. Brouckaert. 2006. Anaphylactic shock depends on PI3K and eNOS-derived NO. J. Clin. Invest. 116:2244-2251.
52. Lowenstein, C.J., and T. Michel. 2006. What's in a name? eNOS and anaphylactic shock. J. Clin. Invest. 116:2075-2078.
53. Huang, P.L., Z. Huang, H. Mashimo, K.D. Bloch, M.A. Moskowitz, J.A. Bevan, and M.C. Fishman. 1995. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 377:239-242.
54. Casanova, E., S. Fehsenfeld, T. Mantamadiotis, T. Lemberger, E. Greiner, A.F. Stewart, and G. Schutz. 2001. A CamKIIalpha iCre BAC allows brain-specific gene inactivation. Genesis. 31:37-42.
55. Muyrers, J.P., Y. Zhang, G. Testa, and A.F. Stewart. 1999. Rapid modification of bacterial artificial chromosomes by ET-recombination. Nucleic Acids Res. 27:1555-1557.
56. Zhang, Y., F. Buchholz, J.P. Muyrers, and A.F. Stewart. 1998. A new logic for DNA engineering using recombination in Escherichia coli. Nat. Genet. 20:123-128.
57. Fleming, I., B. Fisslthaler, M. Dixit, and R. Busse. 2005. Role of PECAM-1 in the shear-stress-induced activation of Akt and the en- dothelial nitric oxide synthase (eNOS) in endothelial cells. J. Cell Sci. 118:4103-4111.
58. He, T.C., S. Zhou, L.T. da Costa, J. Yu, K.W. Kinzler, and B. Vogelstein. 1998. A simplified system for generating recombinant ad-enoviruses. Proc. Natl. Acad. Sci. USA. 95:2509-2514.
59. Hippe, H.J., M. Luedde, S. Lutz, H. Koehler, T. Eschenhagen, N. Frey, H.A. Katus, T. Wieland, and F. Niroomand. 2007. Regulation of cardiac cAMP synthesis and contractility by nucleoside diphosphate kinase B/G protein beta gamma dimer complexes. Circ. Res. 100:1191-1199.
60. Fisslthaler, B., A.E. Loot, A. Mohamed, R. Busse, and I. Fleming. 2008. Inhibition of endothelial nitric oxide synthase activity by proline-rich tyrosine kinase 2 in response to fluid shear stress and insulin. Circ. Res. 102:1520-1528.